IPO registrations (S-1, F-1) · Registrants

Acorda Therapeutics, Inc.

SEC CIK

1008848 · filings on EDGAR ↗

Name on the registration

ACORDA THERAPEUTICS INC

Former names

ACORDA THERAPEUTICS INC (2003–2023)

Registration

Form S-1, first filed 2003-09-29, last 2006-12-04; 3 initial registrations, 12 amendments

Outcome

Final prospectus filed 2006-02-10; declared effective 2006-12-05; withdrawal requested 2003-12-16

Industry (SIC)

Biological Products, (No Diagnostic Substances) 2836

Incorporated in

DE

Business address

TWO BLUE HILL PLAZA, Pearl River, NY 10965

EIN

13-3831168

EDGAR entity type

operating

Insiders and CEO pay

Acorda Therapeutics, Inc. on the corporate pages

Offering terms

Proposed price range

$6.00–$7.00 per share (S-1/A filed 2006-02-09)

Final price

$6.00 per share, within the range (424B4 filed 2006-02-10, an initial public offering)

Shares sold

5,500,000

Gross proceeds

$33,000,000 before underwriting discounts and any over-allotment option

Listing

Nasdaq under the symbol ACOR

Lead underwriters

BofA Securities (2,695,000 shares); Lazard (935,000 shares); Piper Sandler (935,000 shares); Cowen (935,000 shares)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

On this site

• Business registration: ACORDA THERAPEUTICS, INC. EXACT (EIN (EXACT, as the state registration reports it))
• Business registration: Acorda Therapeutics, Inc. Fuzzy (name and state)
• Business registration: ACORDA THERAPEUTICS, INC. Fuzzy (name and state)
• Business registration: ACORDA THERAPEUTICS, INC. Fuzzy (name and state)
• Business registration: ACORDA THERAPEUTICS, INC. Fuzzy (name and state)
• Form 5500 plan sponsor: ACORDA THERAPEUTICS, INC. EXACT (EIN (EXACT))
• Federal award recipient: ACORDA THERAPEUTICS, INC. Fuzzy (name and state)
• Lobbying client: ACORDA THERAPEUTICS Fuzzy (name and state)
• Lobbying client: ACORDA THERAPEUTICS, INC. Fuzzy (name and state)
• SEC filer: Acorda Therapeutics, Inc. EXACT (CIK (EXACT))
• Person page: Ian F Smith Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
• Person page: John P Kelley Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))

Filings 23

Prospectus pages read 2

Officers, directors and large holders Forms 3, 4 and 5

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Biological Products, (No Diagnostic Substances), NY first:

• BRAINSTORM CELL THERAPEUTICS INC. NY
• ANAVEX LIFE SCIENCES CORP. NY
• CytRx Oncology Corp NY
• Omrix Biopharmaceuticals, Inc. NY
• Protara Therapeutics, Inc. NY
• COGNITION THERAPEUTICS INC NY
• Bavarian Nordic A/S / ADR NY
• Qrons Inc. NY
• Prevail Therapeutics Inc. NY
• MeiraGTx Holdings plc NY

More with this interest.

In other datasets, the same topic (Health) in NY:

• Nonprofit: AABR FOUNDATION INC (Nonprofits (IRS Form 990))

Interests: Biological Products, (No Diagnostic Substances) · Health